IP Library Granted Patent US 7,029,900
Granted Patent B2
US 7,029,900 · App. 10/617,361 · Granted Apr 18, 2006

Type II restriction endonuclease BtgZI, obtainable from

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,029,900
App. No.
10/617,361
Granted
Apr 18, 2006
Kind
B2
Abstract

In accordance with the present invention, there is provided a novel restriction endonuclease obtainable from Bacillus thermoglucosidasius 36A (NEB#1384), hereinafter referred to as “BtgZI”, which endonuclease: (1) recognizes the nucleotide sequence 5′-GCGATG-3′ in a double-stranded DNA molecule as shown below, 5′-GCGATGNNNNNNNNNN↓-3′ (SEQ ID NO:9) 3′-CGCTACNNNNNNNNNNNNNN↑-5′  (wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T); (2) cleaves said sequence in the phosphodiester bonds between the 10th and the 11th nucleotides 3′ to the recognition sequence in the 5′-GCGATG-3 strand of the DNA, and between the 14th and 15th nucleotides 5′ to the recognition sequence in the complement stand, 5′-CATCGC-3′, to produce a 4 base 5′ extension; and (3) cleaves double-stranded pBR322 DNA to produce 3 fragments of 2892, 1181 and 288 base pairs.

Claims (7)

1. A substantially pure Type II restriction endonuclease obtainable from Bacillus thermoglucosidasius 36 A (ATCC Accession No. PTA-6692) recognizing the following base sequence in double-stranded deoxyribonucleic acid molecules:

5′-GCGATGNNNNNNNNNN↓-3′

(SEQ ID NO:9)

3′-CGCTACNNNNNNNNNNNNNN↑-5′

and having a cleavage position defined by the arrows.

2. A method for obtaining the Type II restriction endonuclease of claim 1 , comprising cultivating a sample of Bacillus thermoglucosidasius 36A under conditions favoring the production of said endonuclease and separating said endonuclease therefrom.

3. The Type II restriction endonuclease of claim 1 , wherein the restriction endonuclease is purified from Bacillus thermoglucosidasius 36A (ATCC Accession No. PTA-5292).

Assignments (2)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Sep 20, 2023
From: BANK OF AMERICA, N.A. (AS SUCCESSOR-BY-MERGER WITH FLEET NATIONAL BANK)
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 064962/0066 →
SECURITY AGREEMENT Recorded Dec 30, 2003
From: NEW ENGLAND BIOLABS, INC.
To: FLEET NATIONAL BANK
Reel/Frame 014220/0763 →